World's Best Scientists 2026 revealed!
Gastric Cancer
H-index 36

Gastric Cancer

1436-3291

Published by: Springer

https://www.springer.com/journal/10120

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 550 172 252 33

Additional Metrics

Number of Best Scientists*: 264
Documents by Best Scientists*: 310
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 106
SCIMAGO SJR: 2.489
Impact Factor: 5.1

Overview

Top Research Topics at Gastric Cancer?

The journal is mainly concerned with subjects like Cancer, Surgical oncology, Internal medicine, Abdominal surgery and Surgery. Topics in Cancer were tackled in line with various other fields like Survival rate, Cancer research, Lymph node and Stage (cooking). The studies on Cancer research discussed can also contribute to research in the domains of Cancer cell, Cell growth and Carcinogenesis.

While Surgical oncology is the key highlight in it, it also covered some subjects on Early Gastric Cancer and Endoscopic mucosal resection. The Internal medicine works featured in it incorporate elements from Gastroenterology and Oncology. The majority of Gastroenterology studies are focused on the issues of Helicobacter pylori.

Gastric Cancer explores topics in Oncology which can be helpful for research in disciplines like Clinical trial, Phases of clinical research, Cisplatin, Regimen and Docetaxel. The research on Abdominal surgery tackled can also make contributions to studies in the areas of Gastrectomy, Incidence (epidemiology), Randomized controlled trial, Radiology and General surgery. It dives deep in exploring the relationship between the study of Surgery and Lymphadenectomy.

  • Cancer (55.71%)
  • Surgical oncology (53.92%)
  • Internal medicine (48.03%)

What are the most cited papers published in the journal?

  • Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers (1425 citations)
  • Gastric cancer: Asia and the world. (757 citations)
  • Endoscopic resection of early gastric cancer. (569 citations)

Research areas of the most cited articles at Gastric Cancer:

The most cited papers primarily tackle Cancer, Surgical oncology, Internal medicine, Abdominal surgery and Surgery. While the journal articles focused on Cancer, they were also able to explore topics like Survival rate, Lymph node and Pathology. The most cited articles explore topics in Internal medicine which can be helpful for research in disciplines like Gastroenterology and Oncology.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Surgery

The previous edition focused in particular on these issues:

The main points discussed in Gastric Cancer deals with Cancer, Internal medicine, Surgical oncology, Abdominal surgery and Gastroenterology. Some problems in Cancer that were presented in Gastric Cancer overlapped with concepts under Immunohistochemistry, Cancer research, Incidence (epidemiology) and Proportional hazards model. The presented Internal medicine research focuses mostly on Oncology and, on occasion, topics in Trastuzumab.

The work on Surgical oncology tackled in Gastric Cancer brings together disciplines like Biomarker (medicine), Retrospective cohort study, Cancer registry, Stage (cooking) and Cohort. Research on Abdominal surgery presented in it concerns the broader topic of Surgery. Placebo, Nivolumab and Neutropenia are some topics wherein Gastroenterology research discussed in it have an impact.

The most cited articles from the last journal are:

  • Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice. (78 citations)
  • Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. (17 citations)
  • RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription. (12 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Gastric Cancer (based on the number of publications) are:

  • Yasuhiro Kodera (69 papers) published 6 papers at the last edition, 3 more than at the previous edition,
  • Takaki Yoshikawa (66 papers) published 10 papers at the last edition, 4 more than at the previous edition,
  • Masanori Terashima (64 papers) published 12 papers at the last edition, 7 more than at the previous edition,
  • Takeshi Sano (61 papers) published 7 papers at the last edition, 2 more than at the previous edition,
  • Hitoshi Katai (59 papers) published 4 papers at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Gastric Cancer (based on the number of publications) are:

  • Japanese Foundation for Cancer Research (86 papers) published 15 papers at the last edition, 5 more than at the previous edition,
  • Nagoya University (86 papers) published 8 papers at the last edition, 4 more than at the previous edition,
  • Osaka University (74 papers) published 9 papers at the last edition, 3 more than at the previous edition,
  • Keio University (66 papers) published 8 papers at the last edition, 1 less than at the previous edition,
  • New Generation University College (57 papers) published 10 papers at the last edition, 4 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.23% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 40.67% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.00% of all publications and 36.67% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Innovative Research of Past Five Years

The field of gastric cancer research has rapidly advanced in the last five years, with many impactful studies contributing significantly to our understanding and management of this disease. Let's take a look at some innovative research that has taken place in this time frame. A pioneering study that deserves particular mention studied the role of helicobacter pylori in the development of gastric cancer. Its work has resulted in a paradigm shift in how we currently manage such infections, significantly impacting the overall survival rates of those affected with gastric cancer. Another major development in this field is the research on precision therapies. One study specifically evaluated the use of individualized treatment regimens targeting specific genetic mutations commonly found in gastric cancer. The outcomes have shown promising results and have led to more targeted treatment modalities for patients with specific gene mutations. Moreover, surgical advancements have not lagged behind in this rapid progress. The most prominent breakthrough here is the development of less invasive surgical techniques aiming at maximising oncological safety and minimising patient discomfort. Studies have reported favourable survival rates using these techniques, with a considerable decrease in postoperative complications and significantly improved quality of life. While these advancements have undeniably transformed gastric cancer management, for future nurses and health practitioners, it's crucial to constantly update and enhance their skills. For those interested in building a career in this field or furthering their education, the top 10 nursing schools in North Carolina have been recognised as leaders in medical education. Top 10 best nursing schools in North Carolina offer comprehensive courses with a strong emphasis on oncology and internal medicine, which can significantly contribute to training professionals skilled in managing gastric cancer and other malignancies. Their programs provide rigorous clinical training, preparing graduates to lead and influence high-quality health care in gastric cancer. Staying abreast of these breakthroughs in gastric cancer research is crucial in shaping future research and improving patient outcomes. It is widely recognised that harnessing research, alongside continually advancing medical education, will pave the way in improving gastric cancer prognosis.

Top Publications

  • A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

    Li Tzong Chen;Taroh Satoh;Min Hee Ryu;Yee Chao

    (2020)
    206 Citations
  • Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial

    Yoshiaki Iwasaki;Masanori Terashima;Junki Mizusawa;Hiroshi Katayama

    (2021)
    112 Citations
  • Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial.

    Nicole van der Wielen;Jennifer Straatman;Jennifer Straatman;Freek Daams;Riccardo Rosati

    (2021)
    106 Citations
  • Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.

    Charles S Fuchs;Mustafa Özgüroğlu;Yung-Jue Bang;Maria Di Bartolomeo

    (2021)
    103 Citations
  • Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer

    Kohei Yamashita;Masaaki Iwatsuki;Masaaki Iwatsuki;Kazuto Harada;Kazuto Harada;Kojiro Eto

    (2020)
    98 Citations
  • Peritoneal metastasis in gastric cancer: results from the German database.

    Beate Rau;Andreas Brandl;Pompiliu Piso;Jörg Pelz

    (2020)
    96 Citations
  • Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance

    Simon Pernot;Magali Terme;Nina Radosevic-Robin;Florence Castan

    (2020)
    91 Citations
  • Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice.

    Elisabeth M. P. Steeghs;Hans Gelderblom;Vincent K. Y. Ho;Quirinus J. M. Voorham

    (2021)
    87 Citations
  • Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.

    Narikazu Boku;Taroh Satoh;Min Hee Ryu;Yee Chao

    (2021)
    81 Citations
  • A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010).

    Kohei Takizawa;Hiroyuki Ono;Noriaki Hasuike;Atsuo Takashima

    (2021)
    80 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medicine, several related online degree programs can provide valuable skills and certifications. An online nutrition masters offers advanced knowledge in nutrition science, ideal for professionals aiming to specialize in dietetics or wellness coaching.

Another promising option is pursuing a certification in medical imaging. Online sonography certificate programs focus on training students to operate ultrasound technology, a critical tool in diagnostics and patient care. These programs allow for flexible learning while preparing for a rewarding career in diagnostic medical sonography.

Similarly, online radiology programs offer accessible pathways into radiologic technology. These associate degree programs equip students with expertise in imaging techniques, radiation safety, and patient management, essential for roles in hospitals and clinics.

For those targeting a dietetic career, registered dietitian masters programs provide the accredited education necessary to become a licensed dietitian nutritionist. This credential opens doors to clinical, community, and foodservice nutrition careers.

Exploring these related online degrees can complement medical studies and broaden career prospects in healthcare, combining flexibility with specialized training.

Best Scientists Contributing to This Journal

Recently Published Articles